J 2020

Autoimmune pancreatitis - An ongoing challenge

BLAHO, Martin, Petr DÍTĚ, Lumír KUNOVSKÝ a Bohuslav KIANIČKA

Základní údaje

Originální název

Autoimmune pancreatitis - An ongoing challenge

Autoři

BLAHO, Martin (203 Česká republika), Petr DÍTĚ (203 Česká republika), Lumír KUNOVSKÝ (203 Česká republika, domácí) a Bohuslav KIANIČKA (203 Česká republika, garant, domácí)

Vydání

Advances in Medical Sciences, Bialystok, Medical Univ Bialystok, 2020, 1896-1126

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Polsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.287

Kód RIV

RIV/00216224:14110/20:00116220

Organizační jednotka

Lékařská fakulta

UT WoS

000613505100022

Klíčová slova anglicky

Autoimmune pancreatitis; Chronic pancreatitis; IgG4-related disease; Pancreatic insufficiency; Pancreatic cancer

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 4. 2. 2021 11:12, Mgr. Tereza Miškechová

Anotace

V originále

Autoimmune pancreatitis is a rare form of chronic pancreatitis. The first descriptions of the disease date back to the 1990s. Etiology is multifactorial, with the use of genetic, environmental and complex immunological mechanisms. It is classified into two subtypes. Type 1 is part of a group of diseases called IgG4-related disease. Clinically is autoimmune pancreatitis manifested by icterus and abdominal discomfort. It can rarely present as acute pancreatitis. There is also a completely asymptomatic form of the disease. The diagnosis is based on abnormalities in histology, imaging methods, serology, the involvement of other organs in relation to IgG4-related disease, and a significant positive response to corticosteroid therapy. Differential diagnosis between the focal form of autoimmune pancreatitis and pancreatic cancer can be complicated, with endosonography playing an important role. In the treatment, we use corticosteroids and other immunosuppressants including biological therapy. Patients with the asymptomatic disease should also be treated to prevent late complications and exocrine and endocrine insufficiency. In addition to drug treatment, endoscopic and/or surgical treatment may be necessary. Even after recovery, the disease can relapse. The relationship between autoimmune pancreatitis and malignancies has not been clearly confirmed. The goal of this review is to provide a comprehensive look at autoimmune pancreatitis and translate latest scientific knowledge into clinical practice.